🕒 Last update: loading…16/11/2026

Stock Healthpeak Properties, Inc. DOC

Healthpeak Properties, Inc. — Investlytic score 1/5 on the five criteria.

-
-
20/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 1/5 criteria met. Data as of 01/11/2026.

  • ❌ Price trend failed
  • ⚠️ Mixed growth
  • ❌ Debt failed
  • ❌ P/E failed
  • ✅ Correction passed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: 23.42%

Price change 2019 → 2020: -12.30%

Price change 2020 → 2021: 19.38%

Price change 2021 → 2022: -30.53%

Price change 2022 → 2023: -21.02%

Price change 2023 → 2024: 2.37%

Price change 2024 → 2025: -20.67%

Price change 2025 → 2026: 19.19%

Price change 2026 (year to date): 18.30%

Financial growth

Revenue CAGR (8 years): 13.11%

Earnings CAGR (8 years): -32.00%

Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.

Debt

Debt-to-equity ratio: 1.39

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 54.84

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 16.02% from the high over 6 months.

Correction between 10.0% and 20.0% (target range).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Healthpeak Properties, Inc.57.91.39+3.7 %🔒
Unibail-Rodamco-Westfield SE8.31.38+4.9 %–
Vonovia SE3.81.58+10.2 %–
Klépierre7.70.94+4.7 %–
AGNC Investment Corp.5.88.21+11.8 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Healthpeak Properties, Inc. over the latest fiscal years.

Revenue
2.8 bn USD
fiscal year 2025
Net income
71.3 m USD
fiscal year 2025
Net margin
2.5 %
fiscal year 2025
Average annual growth
+11.4 %
Revenue growth over 5 years
Average annual growth
+3.8 %
Revenue growth over 10 years
Market cap
13.8 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
20201.6 bn414 m25.1 %n/a
20211.9 bn506 m26.7 %+15.3 %
20222.1 bn500 m24.3 %+8.7 %
20232.2 bn306 m14.0 %+5.8 %
20242.7 bn243 m9.0 %+23.8 %
20252.8 bn71.3 m2.5 %+4.5 %

Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Healthpeak Properties, Inc. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
fragile accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
0.42
risk zone (below 1.81)
Piotroski Score
7 / 9
7 to 9: solid accounts
DCF Value
33.34 USD
DCF above share price · share price 20.27 USD, gap +64.4 %
Net Debt / EBITDA
5.20 x
high debt
Fiscal year20212022202320242025
Cash and investments158 m72.0 m118 m120 m538 m
Total Debt6.4 bn6.7 bn7.1 bn9.0 bn10.4 bn
Net Debt6.2 bn6.6 bn7.0 bn8.9 bn9.9 bn
Equity6.5 bn6.7 bn6.4 bn8.4 bn7.5 bn
Total assets15.3 bn15.8 bn15.7 bn19.9 bn20.3 bn
Operating cash flow795 m900 m956 m1.1 bn1.3 bn
Investments (capex)00000
Free cash-flow795 m900 m956 m1.1 bn1.3 bn
Share buybacks12.8 m67.8 m6.5 m191 m97.1 m
Dividends paid650 m648 m657 m795 m849 m

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)37.26 x
Price / book value1.76 x
Return on Equity (ROE)5.0 %
Return on Invested Capital (ROIC)2.4 %
Net margin12.7 %
Debt / equity1.23 x
Current ratio0.22 x
Interest coverage1.44 x
Free cash-flow yield2.4 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.

+

Valuation and competitors

Healthpeak Properties, Inc. compared with its sector on the same exchange and with its main competitors.

Company P/E
57.1
29.5 % above the sector
Sector median P/E
44.1
real estate, NYSE
Sector over 10 years
42.7
10-year median, range 32.2 to 55.6

Direct competitors

CompanyMarket cap (USD)P/ENet margin
Healthpeak Properties, Inc.13.8 bn57.12.5 %
Omega Healthcare Investors, Inc. OHI14.3 bn16.149.2 %
CareTrust REIT, Inc. CTRE9.8 bn24.467.3 %
Sabra Health Care REIT, Inc. SBRA5.4 bn77.420.1 %
American Healthcare REIT, Inc. AHR13.4 bn85.03.1 %
LTC Properties, Inc. LTC2.4 bn16.044.9 %
National Health Investors, Inc. NHI3.1 bn17.937.6 %
Welltower Inc. WELL179 bn105.88.8 %
Sector median (NYSE)44.1

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 11/11/2026. Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Healthpeak Properties, Inc. publish: ratings, price targets and earnings forecasts.

Majority rating
hold
41 analysts
Average price target
22.00 USD
from 20.00 USD to 24.00 USD, 20 targets over 12 months
Gap with the share price
+8.6 %
price 20.26 USD on 06/11/2026

Breakdown of ratings

strong buy 0buy 19hold 22sell 0strong sell 0

Analysts' average target 22.00 USD, DCF value 33.34 USD, share price 20.26 USD.

Average target over the last 3 months: 21.50 USD (4 targets).

Analyst forecasts

Fiscal yearRevenueNet incomeExpected EPS (range)P/E on this EPSAnalysts
20263.0 bn319 m0.46 (0.45 / 0.46)43.92
20273.1 bn154 m0.22 (0.21 / 0.23)91.84
20283.4 bn202 m0.29 (0.26 / 0.31)69.82

Amounts in USD, the reporting currency.

Track record against expectations: reported EPS above consensus 6 times over the last 12 releases.

Rating changes (12 months)

DateFirmBeforeAfter
11/11/2026UBSNeutralNeutral
06/11/2026Evercore ISI GroupIn LineIn Line
04/11/2026Cantor FitzgeraldNeutralNeutral
19/10/2026Wells FargoEqual WeightEqual Weight
13/10/2026UBSNeutralNeutral

Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Healthpeak Properties, Inc.

Free float
99.6 %
share of freely traded shares
Large funds tracked
25
hold the stock as of 2026Q2
Executives (insiders)
0 / 1
0 purchases, 1 sales in 130 days
US elected officials
2
2 purchases, 0 sales in 12 months

Indices: S&P 500 (since 31/03/2008).

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
State Street88.0 m1.9 bn0.0 %+81.5 %2026Q2
Vanguard Group109 m1.8 bn0.0 %-0.3 %2025Q4
BlackRock70.9 m1.5 bn0.0 %-3.3 %2026Q2
JPMorgan Chase30.2 m661 m0.0 %-32.5 %2026Q2
Geode Capital Management24.7 m527 m0.0 %+1.0 %2026Q2
Invesco18.5 m396 m0.0 %-23.4 %2026Q2
Morgan Stanley14.2 m304 m0.0 %+15.3 %2026Q2
Goldman Sachs11.5 m247 m0.0 %+59.2 %2026Q2

Latest insider transactions

DatePersonSideAmount
09/11/2026Patadia Ankit B.sale127,070 USD

Elected officials' disclosures

DateOfficialSideAmount
27/03/2026Alan Armstrongpurchase$1,001 - $15,000
09/01/2026Gilbert Cisnerospurchase$1,001 - $15,000

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 16/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
NYSE
IPO: 23/05/1985
ISIN code
US42250P1030
Workforce
387
full-time employees
Chief executive
Scott M. Brinker
Next earnings
01/02/2027

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Healthpeak Properties, Inc.

What is the Healthpeak Properties, Inc. share price?

Latest recorded price: 19.98 USD on 13/11/2026, for a market cap of 13.8 bn USD.

What is the revenue of Healthpeak Properties, Inc.?

2.8 bn USD for fiscal year 2025, with net income of 71.3 m USD (net margin 2.5 %).

When does Healthpeak Properties, Inc. report its next earnings?

The next release is expected on 01/02/2027. EPS expected by analysts: 0.04.

What do analysts say about Healthpeak Properties, Inc.?

Out of 41 analysts: 19 buy or strong buy, 22 hold, 0 sell or strong sell. Average price target: 22.00 USD, i.e. +8.6 % from the share price.

What is the P/E ratio of Healthpeak Properties, Inc.?

Trailing 12-month P/E of 57.1, against 44.1 for the sector median on the same exchange (10-year median: 42.7).

Is Healthpeak Properties, Inc. stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US42250P1030).

How many employees does Healthpeak Properties, Inc. have?

387 full-time employees according to the latest published profile.

Who runs Healthpeak Properties, Inc.?

Scott M. Brinker is the company's chief executive.

Which large funds own Healthpeak Properties, Inc.?

As of 2026Q2, among the large funds tracked: State Street, Vanguard Group, BlackRock, JPMorgan Chase, Geode Capital Management.

07

Similar stocks